4200 Participants Needed

Airway & Compression Techniques for Cardiac Arrest

(FACT Trial)

JB
Overseen ByJenny B Shin
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Washington
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment Airway & Compression Techniques for Cardiac Arrest?

Research shows that the i-gel, a device used to keep the airway open, is easier and faster to insert during CPR, which can help maintain effective chest compressions. Additionally, studies suggest that chest compression rates of 100-120 per minute are recommended, but higher rates may increase blood flow, potentially improving outcomes during cardiac arrest.12345

Is the airway and compression technique for cardiac arrest safe for humans?

The research articles focus on the quality and effectiveness of chest compressions and airway devices during CPR, but they do not provide specific safety data for humans.678910

How does the treatment using Compression Rate and i-gel differ from other treatments for cardiac arrest?

The treatment using Compression Rate and i-gel is unique because it focuses on optimizing the rate of chest compressions during CPR and uses the i-gel airway device, which is a simple, non-inflatable mask that provides a clear airway quickly and effectively, potentially improving outcomes during cardiac arrest compared to traditional methods.1112131415

What is the purpose of this trial?

The First responder Airway \& Compression rate Trial (FACT) Study will address basic life support (BLS) treatments administered by Emergency Medical Services (EMS) first responders to patients who suffer a sudden circulatory (pulseless) collapse, referred to as sudden out-of-hospital cardiac arrest (SCA). The investigators propose a randomized controlled trial among persons who suffer SCA to compare these two rescue breathing approaches (standard Bag Valve Mask vs i-gel) along with evaluating a more precise chest compression rate within the range of 100-120 compressions per minute during CPR. Importantly, each of these treatments fall within established resuscitation guidelines and are already administered as part of standard care in clinical practice. Thus this proposed trial will essentially be comparing one standard-of-care treatment against another standard-of-care treatment.The study will address two primary aims:Aim 1: To compare survival to hospital discharge between SCA patients randomized to BVM versus the i-gel for rescue breathing. The hypothesis is that treatment with i-gel will result in a higher rate of survival to hospital discharge than BVM.Aim 2: To compare survival to hospital discharge between SCA patients randomized to chest compression rates of 100 versus 110 versus 120 per minute. The hypothesis is that treatment with 100 chest compressions per minute will result in a higher rate of survival to hospital discharge than compression rates of 110 or 120 per minute.

Research Team

TR

Thomas Rea, MD

Principal Investigator

University of Washington

Eligibility Criteria

This trial is for adults in Seattle and greater King County who experience a sudden, non-traumatic cardiac arrest outside of the hospital where EMS will attempt resuscitation.

Inclusion Criteria

Adults suffering out-of-hospital non-traumatic SCA in Seattle and greater King County in whom resuscitation will be attempted by first responding EMS personnel.

Exclusion Criteria

Other protected populations (pediatrics)
Known prisoner
Known pregnancy
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive basic life support treatments including rescue breathing with either BVM or i-gel and chest compressions at varying rates

Immediate intervention during cardiac arrest event

Follow-up

Participants are monitored for survival to hospital discharge and neurological function

6 months

Treatment Details

Interventions

  • Compression Rate
  • i-gel
Trial Overview The FACT Study compares two rescue breathing methods (standard Bag Valve Mask vs i-gel) and three chest compression rates (100, 110, or 120 per minute) during CPR to see which leads to better survival rates after cardiac arrest.
Participant Groups
2Treatment groups
Active Control
Group I: Compression RateActive Control1 Intervention
Each of 28 first responder EMS agencies in King County will be randomly assigned with one of the three chest compression rates (100 vs 110 vs 120) at the outset.
Group II: Airway StrategyActive Control1 Intervention
Each of 28 first responder EMS agencies in King County will be randomly assigned to treat with either the BVM or i-gel for airway strategy

Compression Rate is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Chest Compression Rate for:
  • Cardiac arrest
  • Sudden circulatory collapse
🇪🇺
Approved in European Union as Cardiopulmonary Resuscitation (CPR) Rate for:
  • Out-of-hospital cardiac arrest
  • Cardiac emergency
🇨🇦
Approved in Canada as Chest Compression Rate for:
  • Sudden cardiac arrest
  • Cardiopulmonary emergency

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Washington

Lead Sponsor

Trials
1,858
Recruited
2,023,000+

Findings from Research

The i-gel™ supraglottic airway device demonstrated a high first-attempt insertion success rate of 90% among paramedics and emergency physicians during CPR, indicating it is easy to use in emergency situations.
Ventilation was adequate in 96% of CPR attempts, and the i-gel™ allowed for continuous chest compressions without interruptions in 74% of cases, supporting its effectiveness in maintaining ventilation while minimizing pauses in chest compressions.
Performance of the i-gel™ during pre-hospital cardiopulmonary resuscitation.Häske, D., Schempf, B., Gaier, G., et al.[2019]
The i-gel has a higher success rate for airway management in cardiac arrest patients (94% and 92%) compared to endotracheal tube insertion (90% and 86%), making it a preferred choice for prehospital resuscitation.
The use of i-gel is increasing among emergency staff, as it allows for faster insertion and enables quicker progression to other resuscitation efforts, although some staff still prefer ET tubes due to confidence issues with new equipment.
Introduction of the I-gel supraglottic airway device for prehospital airway management in a UK ambulance service.Duckett, J., Fell, P., Han, K., et al.[2016]
Nursing staff can successfully use the I-gel and the intubating laryngeal mask Fastrach (ILMA) for airway management during cardiopulmonary resuscitation, demonstrating comparable success rates in a mannequin study with 45 participants.
The ILMA was found to be more successful than the I-gel in securing the airway, although both devices experienced longer intubation times when chest compressions were ongoing.
Comparison of blind intubation through the I-gel and ILMA Fastrach by nurses during cardiopulmonary resuscitation: a manikin study.Melissopoulou, T., Stroumpoulis, K., Sampanis, MA., et al.[2018]

References

Performance of the i-gel™ during pre-hospital cardiopulmonary resuscitation. [2019]
Introduction of the I-gel supraglottic airway device for prehospital airway management in a UK ambulance service. [2016]
Comparison of blind intubation through the I-gel and ILMA Fastrach by nurses during cardiopulmonary resuscitation: a manikin study. [2018]
Association between chest compression rates and clinical outcomes following in-hospital cardiac arrest at an academic tertiary hospital. [2022]
[Role of the i-gel in emergency airway management]. [2014]
The impact of chest compression rates on quality of chest compressions - a manikin study. [2022]
Diagnostic performance of a new multifunctional electrocardiograph during uninterrupted chest compressions in cardiac arrest patients. [2019]
Effective compression ratio--a new measurement of the quality of thorax compression during CPR. [2013]
Benefit of cardiac sonography for estimating the early term survival of the cardiopulmonary arrest patients. [2021]
Hands-off time during insertion of six airway devices during cardiopulmonary resuscitation: a randomised manikin trial. [2011]
11.United Statespubmed.ncbi.nlm.nih.gov
Double-balloon technique for embolization of carotid cavernous fistulas. [2021]
Super-Elastic Carbonized Mushroom Aerogel for Management of Uncontrolled Hemorrhage. [2023]
Intraprocedural rupture management for intracranial aneurysm rupture during coil embolization by manual common carotid artery compression. [2019]
Treatment of carotid-cavernous fistula using a balloon-tipped intra-arterial catheter. [2019]
15.United Statespubmed.ncbi.nlm.nih.gov
Brachial plexus and supraclavicular nerve injury caused by manual carotid compression for spontaneous carotid-cavernous sinus fistula. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security